Cargando…
Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers
There is a critical requirement for alternative strategies to provide the better treatment in colorectal cancer (CRC). Hence, our goal was to propose novel biomarkers as well as drug candidates for its treatment through differential interactome based drug repositioning. Differentially interacting pr...
Autores principales: | Beklen, Hande, Arslan, Sema, Gulfidan, Gizem, Turanli, Beste, Ozbek, Pemra, Karademir Yilmaz, Betul, Arga, Kazim Yalcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581026/ https://www.ncbi.nlm.nih.gov/pubmed/36303724 http://dx.doi.org/10.3389/fbinf.2021.710591 |
Ejemplares similares
-
Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
por: Beklen, Hande, et al.
Publicado: (2020) -
Pan-cancer mapping of differential protein-protein interactions
por: Gulfidan, Gizem, et al.
Publicado: (2020) -
Systems-level biomarkers identification and drug repositioning in colorectal cancer
por: Beklen, Hande, et al.
Publicado: (2021) -
Current State of “Omics” Biomarkers in Pancreatic Cancer
por: Turanli, Beste, et al.
Publicado: (2021) -
Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
por: Kori, Medi, et al.
Publicado: (2023)